Tianwei Ellen Zhou

Tianwei Ellen Zhou

Auto-generated profile, based on publicly available information

Tianwei Ellen Zhou

Department of Ophthalmology & Visual Sciences, University of Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2018 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
TBTanguy Boutin
Tanguy Boutin
ZMZale Mednick
Zale Mednick
TZTianwei Ellen Zhou
Tianwei Ellen Zhou
MSMahmood Showail
Mahmood Showail
AEAdi Einan-Lifshitz
Adi Einan-Lifshitz
ASAllan R. Slomovic
Allan R. Slomovic

1 December 2019 in Annals of Eye Science
Verified
Journal Article
Open access
TZTianwei E. Zhou
Tianwei E. Zhou
DSDiane N. Sayah
Diane N. Sayah
MLMark R. Lesk
Mark R. Lesk

29 December 2019 in Clinical & Investigative Medicine
Verified
Journal Article
Open access
PDF file
SASonia Anchouche
Sonia Anchouche
JLJiaru Liu
Jiaru Liu
SVSara Vucetic
Sara Vucetic
KSKim Santerre
Kim Santerre
TZTianwei E. Zhou
Tianwei E. Zhou
The Vision Health Research Network (VHRN) is a provincial scientific organization that aims to improve the ocular health of patients across Quebec by supporting local research endeavors in vision health. The VHRN Student Committee, composed of 288 trainees with diverse backgrounds, has demonstrated its commitment to the scholarly development of its members by providing leadership opportunities, creating networking events, increasing visibility of researchers-in-training and encouraging professional advancement through educational workshops and funding programs. In this article, we review the contributions of the VHRN Student Committee and discuss its future projects.

9 February 2026 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
TZTianwei Ellen Zhou
Tianwei Ellen Zhou
PKPeter John Kertes
Peter John Kertes
NNNasrin Najm-Tehrani
Nasrin Najm-Tehrani
KMKamiar Mireskandari
Kamiar Mireskandari
Retinopathy of prematurity (ROP) is the leading cause of childhood blindness worldwide. While choroidal involution has been described in animal models, choroidal perfusion in premature infants remains poorly characterized because of limited use of intravenous fluorescein angiography (IVFA). This retrospective study systematically analyzed IVFAs performed post-treatment in patients with ROP at the Hospital for Sick Children between 2011 and 2020. Eligible patients had received intravitreal bevacizumab or laser photocoagulation, and only transiting eyes were included to allow complete IVFA phase analysis. Three independent experts graded each IVFA for image quality, presence of delayed choroidal perfusion during the arteriovenous phase, and its location (central, peripheral, or multifocal). Inter-rater reliability was assessed using Fleiss's κ. Of 79 IVFAs reviewed, 74 met quality criteria. The cohort had an average birth weight of 602.6 g and a gestational age of 24.0 weeks. Most (63.5%) had zone I, stage 3+ ROP. IVFAs were conducted at a corrected age of 7.5 months. Delayed choroidal perfusion was found in 64 eyes (86.5%), predominantly multifocal. Only 2 eyes had normal perfusion. Inter-rater agreement was high (κ = 0.85). Delayed choroidal perfusion is common and persistent in treated ROP patients. To our knowledge, this is the largest IVFA series that systematically describes this underrecognized feature with implications for long-term vision.

20 May 2024 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
TZTianwei Ellen Zhou
Tianwei Ellen Zhou
PKPeter Kertes
Peter Kertes
NNNasrin Najm-Tehrani
Nasrin Najm-Tehrani
KMKamiar Mireskandari
Kamiar Mireskandari